PLoS ONE (Jan 2016)

Correction: An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy.

  • Josep M Llibre,
  • François Raffi,
  • Graeme Moyle,
  • Georg Behrens,
  • Stephane Bouee,
  • Geraldine Reilly,
  • Peter Borg,
  • David Piontkowsky,
  • Felipe Rogatto

DOI
https://doi.org/10.1371/journal.pone.0159286
Journal volume & issue
Vol. 11, no. 7
p. e0159286

Abstract

Read online

[This corrects the article DOI: 10.1371/journal.pone.0155406.].